Zoltán Kaló and colleagues consider approaches to counter systemic inequities and power imbalances arising from discrete national policies for drug pricing and reimbursement Current pricing mechanisms ...

Tarang Sharma and colleagues argue for increased collaboration across public and private sectors—internationally and with patients—in drug assessment and managed entry agreements to support equitable ...